SB 271 amends Kentucky law governing ocular devices that contain and deliver pharmaceutical agents, such as certain contact lenses or similar prescription eye devices. The bill specifies that these devices, when approved by the FDA as a drug and prescribed by a physician, osteopath, or authorized optometrist, must be fitted by either an ophthalmologist or an optometrist. It also allows dispensing of these devices by a licensed optometrist or ophthalmologist.
The bill further clarifies that the section does not expand an optometrist’s prescriptive authority and does not interfere with a pharmacist’s ability to dispense a valid prescription for an ocular device containing a pharmaceutical agent. In practical terms, the measure is aimed at clarifying professional roles in the fitting and dispensing of medicated ocular devices rather than creating a new category of authority.
Impact
SB 271 would amend KRS 320.410 to clarify the scope of practice and responsibilities for ophthalmologists, optometrists, and pharmacists regarding FDA-approved ocular devices that deliver pharmaceutical agents. It affects the regulation of prescription eye devices and the interaction between Chapters 311, 315, and 320 of Kentucky law, while expressly preserving existing prescriptive limits for optometrists and pharmacists’ dispensing authority.
Sentiment
Based on the bill text and the absence of recorded committee debate or votes in the provided materials, the bill appears to be a technical or clarifying measure rather than a controversial policy change. The language suggests an effort to align professional practice rules and reduce ambiguity among eye-care providers and pharmacists, which typically draws neutral or supportive treatment when no expansion of authority is intended.
Contention
The main potential point of contention is professional scope of practice: ophthalmologists, optometrists, and pharmacists each have defined roles in prescribing, fitting, and dispensing ocular devices. The bill explicitly states it does not expand optometrists’ prescriptive authority or restrict pharmacists, indicating that any concern would likely center on ensuring the bill is read as a clarification rather than a shift in authority or market access for providers.